tiprankstipranks
Santhera Pharmaceuticals Holding (SPHDF)
OTHER OTC:SPHDF
Want to see SPHDF full AI Analyst Report?

Compare Santhera Pharmaceuticals Holding (SPHDF) vs. Competitors

39 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Santhera Pharmaceuticals Holding
$22.28
$327.09M
-0.98
28.76%
1 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.41
CHF133.24M
-2.50
3.48%
1 Buy
0 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF52.60
CHF692.07M
16.63
35.84%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.71
CHF927.76M
-8.17
225.79%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF16.28
CHF352.87M
-9.69
154.49%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF21.80
CHF124.00M
3.99
14.50%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SPHDF
Santhera Pharmaceuticals Holding
22.28
4.85
27.87%
CH:MOLN
Molecular Partners AG
3.27
0.11
3.48%
CH:BSLN
Basilea Pharmaceutica
56.10
14.80
35.84%
CH:IDIA
Idorsia Ltd
3.71
2.57
225.79%
CH:NWRN
Newron Pharmaceuticals SpA
16.44
9.68
143.20%
CH:XLS
Xlife Sciences Ltd.
22.90
-0.90
-3.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts